|
TVIS20024653
|
Human Papillomavirus |
HPV16 |
K02718 |
3095 |
- |
hg38 |
chr4 |
125523187 |
125523187 |
q28.1 |
ENSG00000302594 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024654
|
Human Papillomavirus |
HPV16 |
K02718 |
3009 |
- |
hg38 |
chr4 |
125525400 |
125525400 |
q28.1 |
ENSG00000302594 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024655
|
Human Papillomavirus |
HPV16 |
K02718 |
491 |
- |
hg38 |
chr4 |
125513790 |
125513790 |
q28.1 |
ENSG00000302594 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024656
|
Human Papillomavirus |
HPV16 |
K02718 |
4364 |
- |
hg38 |
chr17 |
40933796 |
40933796 |
q21.2 |
ENSG00000234477, KRT23 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024657
|
Human Papillomavirus |
HPV16 |
K02718 |
4398 |
- |
hg38 |
chr16 |
56745910 |
56745910 |
q13 |
NUP93 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024658
|
Human Papillomavirus |
HPV16 |
K02718 |
5877 |
- |
hg38 |
chr8 |
122123631 |
122123631 |
q24.13 |
ENSG00000254303 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024659
|
Human Papillomavirus |
HPV16 |
K02718 |
2768 |
- |
hg38 |
chr4 |
139899865 |
139899865 |
q31.1 |
MAML3 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024660
|
Human Papillomavirus |
HPV16 |
K02718 |
2568 |
- |
hg38 |
chr4 |
139900190 |
139900190 |
q31.1 |
MAML3 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024661
|
Human Papillomavirus |
HPV16 |
K02718 |
2142 |
- |
hg38 |
chr4 |
123930571 |
123930571 |
q28.1 |
LINC01091 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
|
TVIS20024662
|
Human Papillomavirus |
HPV16 |
K02718 |
934 |
- |
hg38 |
chr1 |
15327982 |
15327982 |
p36.21 |
FHAD1, EFHD2-AS1, FHAD1-AS1 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |